Skip to content

Skin Practice

Active
Private limited companyfounded 20187 yrs activeSint-Annalaan 93A, 1853 Grimbergen, BelgiumKBO/BCE: BE 0713.498.049

Skin Practice has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20k and a net result of €85k. Equity is shrinking by ~13.8% per year across the filed fiscal years. Its solvency ranks better than 19% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
76 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency43▲+1
Growth58=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1.5k at 30 days acceptable
Liquidity short (current ratio 0.75 against 0.67 in 2024; short-term debt: 82.1% and cash: 57.9% of total assets), and 82.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 7 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
17.9%
Return on assets
74.1%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 16491 sector peers (2025).
NBB · sector comparison
Position among 16491 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-04-2026, 92 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
92 d early
2024
44 d early
2023
40 d early
2022
49 d early
2021
39 d early
2020
31 d early
2019
30 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€20k▲ 3.7%
2024 · €20k
2019: €32k 2020: €66k 2021: €131k 2022: €32k 2023: €21k 2024: €20k
2019 → 2025
Total assets
€114k▼ 0.9%
2024 · €115k
2019: €106k 2020: €126k 2021: €179k 2022: €217k 2023: €134k 2024: €115k
2019 → 2025
Net result
€85k▼ 0.6%
2024 · €85k
2019: €19k 2020: €34k 2021: €59k 2022: €70k 2023: €85k 2024: €85k
2019 → 2025
Working capital
€-23k▲ 24.9%
2024 · €-31k
2019: €58k 2020: €78k 2021: €136k 2022: €-34k 2023: €-36k 2024: €-31k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€131k-€32k▼ 75.7%€21k▼ 32.6%€20k▼ 8.3%€20k▲ 3.7%
Operating result€76k-€86k▲ 13.3%€107k▲ 24.5%€108k▲ 1.3%€107k▼ 0.8%
Net result€59k-€70k▲ 18.8%€85k▲ 20.0%€85k▲ 0.7%€85k▼ 0.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2021: €76k€76kNet result 2021: €59k€59kOperating result 2022: €86k€86kNet result 2022: €70k€70kOperating result 2023: €107k€107kNet result 2023: €85k€85kOperating result 2024: €108k€108kNet result 2024: €85k€85kOperating result 2025: €107k€107kNet result 2025: €85k€85k20212022202320242025
The operating result falls in 2025; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €114k
Fixed assets €44k▼ 13.9%
Current assets €70k▲ 9.3%
Equity and liabilities €114k
Equity €20k▲ 3.7%
Debt €94k▼ 1.9%
The debt ratio falls from 82.9% to 82.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€117k
2024 · €117k
Cash flow
€94k
2024 · €94k
Solvency
17.9%
2024 · 17.1%
Current ratio
0.75
2024 · 0.67
Quick ratio
0.75
2024 · 0.67
Debt / equity
4.60
2024 · 4.86
ROE
415.0%
2024 · 432.9%
ROA
74.1%
2024 · 73.8%
Interest coverage
305.06
2024 · 221.01
Debt
€94k
2024 · €96k
Debt ≤ 1 year
€94k
2024 · €96k
Income taxes
€22k
2024 · €22k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€115k€114k
Fixed assets21/28€51k€44k
Tangible fixed assets22/27€51k€44k
Plant, machinery and equipment23€41k€34k
Furniture and vehicles24€2k€1k
Other tangible fixed assets26€8k€8k
Current assets29/58€64k€70k
Amounts receivable within one year40/41€3k€4k
Other amounts receivable41€3k€4k
Cash at bank and in hand54/58€62k€66k
Deferred charges and accrued income490/1€200€0
Equity and liabilities
Total equity and liabilities10/49€115k€114k
Equity10/15€20k€20k
Contributions10/11€19k€19k=
Reserves13€1k€1k=
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€1k€1k=
Profit (loss) carried forward14€86€815
Amounts payable17/49€96k€94k
Amounts payable within one year42/48€96k€94k
Trade debts44€5k€3k
Suppliers440/4€5k€3k
Taxes, remuneration and social security45€0-
Taxes450/3€0-
Remuneration and social security454/9€0-
Other amounts payable47/48€91k€90k
Accrued charges and deferred income492/3€0-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€9k
Other operating charges640/8€0€453
Gross operating margin9900€117k€117k
Operating profit (loss)9901€108k€107k
Financial income75/76B€1€3
Recurring financial income75€1€3
Financial charges65/66B€530€382
Recurring financial charges65€530€382
Profit (loss) for the period before taxes9903€107k€107k
Income taxes67/77€22k€22k
Profit (loss) for the period9904€85k€85k
Profit (loss) for the period to be appropriated9905€85k€85k
Appropriation of the result
Profit (loss) to be appropriated9906€87k€85k
Profit (loss) brought forward from the previous period14P€2k€86
Transfer from equity791/2€1k€0
Transfer to equity691/2€1k€0
To other reserves6921€1k€0
Profit to be distributed694/7€87k€84k
Return on contributions (dividend)694€87k€84k

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-04
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
17-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2019net €85k ▲0.7%
Operating result €108k, net result €85k, both a record.
21-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
12-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
22-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Equity above €100kEq €131k ▲99.5%
3 profitable years in a row build equity to €131k.
30-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
01-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Grimbergen · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Sint-Annalaan 93A1853 Grimbergen
Ground area
612 m²
Building footprint
145 m²
Volume, LiDAR
999 m³
Parcel 23084A0351/00X003, Flanders · tallest building 9.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Sint-Annalaan 93A, 1853 Grimbergen
Specialist medical practice
since 20182.282.009.924
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23084A0351/00X003 Flanders 612 m² 1 · 145 m² 9.4 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,972. 3,191 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded13-11-2018
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86109Human health activities
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.